133 related articles for article (PubMed ID: 37078179)
21. Use of propranolol in infantile haemangioma among Chinese children.
Chik KK; Luk CK; Chan HB; Tan HY
Hong Kong Med J; 2010 Oct; 16(5):341-6. PubMed ID: 20889997
[TBL] [Abstract][Full Text] [Related]
22. Color Doppler Ultrasound Indices as Predictors of Propranolol Response in Infantile Hemangioma: A Prospective Study.
Pandey V; Bera RN; Diwedi AND; Singh OP; Tiwari P
Indian Pediatr; 2024 Mar; 61(3):237-242. PubMed ID: 38469839
[TBL] [Abstract][Full Text] [Related]
23. [Rapid regression of infantile haemangioma with 2% propranolol ointment].
Mouhari-Toure A; Azoumah KD; Tchamdja K; Saka B; Kombaté K; Tchangaï-Walla K; Pitche P
Ann Dermatol Venereol; 2013; 140(6-7):462-4. PubMed ID: 23773747
[TBL] [Abstract][Full Text] [Related]
24. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
Holmes WJ; Mishra A; Gorst C; Liew SH
J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
[TBL] [Abstract][Full Text] [Related]
25. Safety assessment of propranolol for infantile hemangioma: a study in an Asian population.
Yu L; Wei L; Xu Z; Zhang B; Han X; Sun Y; Liu Y; Wang C; Qiu L; Xiu B; He R; Li L; Ma L
Expert Rev Clin Pharmacol; 2022 Feb; 15(2):237-242. PubMed ID: 34918994
[TBL] [Abstract][Full Text] [Related]
26. Propranolol for infantile haemangiomas: initiating treatment on an outpatient basis.
Dyme JL; Thampan A; Han EJ; Nyirenda TL; Kotb ME; Shin HT
Cardiol Young; 2012 Aug; 22(4):424-9. PubMed ID: 22166728
[TBL] [Abstract][Full Text] [Related]
27. Propranolol therapy for cutaneous infantile haemangiomas initiated safely as a day-case procedure.
McSwiney E; Murray D; Murphy M
Eur J Pediatr; 2014 Jan; 173(1):63-8. PubMed ID: 23933667
[TBL] [Abstract][Full Text] [Related]
28. Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma.
Hermans MM; Breugem CC; Schappin R; Jonge Poerink E; Mendels EJ; Ragamin A; Breur JMPJ; Langeveld HR; Raphael MF; De Laat PCJ; De Wildt SN; Rietman AB; Pasmans SGMA; De Graaf M
Acta Derm Venereol; 2022 Oct; 102():adv00788. PubMed ID: 35506358
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Propranolol Gel for Infantile Hemangioma: A Randomized, Double-Blind Study.
Rikihisa N; Takatsuka H; Suzuki T; Shiko Y; Kawasaki Y; Hanawa M; Ishii I; Mitsukawa N
Biol Pharm Bull; 2022 Jan; 45(1):42-50. PubMed ID: 34719577
[TBL] [Abstract][Full Text] [Related]
30. Safety of oral propranolol for neonates with problematic infantile hemangioma: a retrospective study in an Asian population.
Fu R; Zou Y; Wu Z; Jin P; Cheng J; Bai H; Huang M; Huan X; Yuan H
Sci Rep; 2023 Apr; 13(1):5956. PubMed ID: 37046020
[TBL] [Abstract][Full Text] [Related]
31. A retrospective analysis of systemic propranolol for the treatment of complicated infantile haemangiomas.
Schneider M; Cremer HJ; Ruef P
Acta Paediatr; 2014 Sep; 103(9):977-83. PubMed ID: 24837972
[TBL] [Abstract][Full Text] [Related]
32. Low-dose propranolol for infantile haemangioma.
Tan ST; Itinteang T; Leadbitter P
J Plast Reconstr Aesthet Surg; 2011 Mar; 64(3):292-9. PubMed ID: 20615772
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas.
Puttgen KB; Summerer B; Schneider J; Cohen BA; Boss EF; Bauman NM
Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):550-4. PubMed ID: 24224397
[TBL] [Abstract][Full Text] [Related]
34. Low-dose propranolol for infantile hemangioma of the head and neck: Analysis of 23 consecutive patients.
Ren W; Li S; Gao L; Huang S; Zhang L; Qiang C; Liu C; Zhi K
Pediatr Int; 2017 Feb; 59(2):213-217. PubMed ID: 27473874
[TBL] [Abstract][Full Text] [Related]
35. Capillary haemangioma successfully treated with oral beta-blocker in Dar es Salaam, Tanzania: a case report.
Cloke A; Lim LT; Blaikie A
Semin Ophthalmol; 2013 Jan; 28(1):32-3. PubMed ID: 23305438
[TBL] [Abstract][Full Text] [Related]
36. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol.
Vassallo P; Forte R; Di Mezza A; Magli A
Am J Ophthalmol; 2013 Jan; 155(1):165-170.e2. PubMed ID: 22967870
[TBL] [Abstract][Full Text] [Related]
37. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
[TBL] [Abstract][Full Text] [Related]
38. Propranolol for infantile haemangiomas: a review.
Starkey E; Shahidullah H
Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
[TBL] [Abstract][Full Text] [Related]
39. Propranolol and infantile hemangiomas four years later: a systematic review.
Marqueling AL; Oza V; Frieden IJ; Puttgen KB
Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852
[TBL] [Abstract][Full Text] [Related]
40. Adverse Drug Reactions Following Propranolol in Infantile Hemangioma.
Pandey V; Tiwari P; Imran M; Mishra A; Kumar D; Sharma SP
Indian Pediatr; 2021 Aug; 58(8):753-755. PubMed ID: 34465658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
